Investor Relations
Corporate Governance
BOARD OF DIRECTORS

Our Board consists of 7 Directors, of whom 3 are executive Directors, 1 is non-executive Director and 3 are independent non-executive Directors. Our Board is responsible for and has general powers for the management and conduct of our business.

BOARD COMMITTEES

We have established the following committees in our Board: an audit committee, a remuneration committee and a nomination committee. The committees operate in accordance with terms of reference established by our Board.


Audit Committee

We have established an audit committee (with effect from the Listing Date) with written terms of reference in compliance with Rule 3.21 of the Listing Rules and paragraph C.3 and paragraph D.3 of the Corporate Governance Code as set out in Appendix 14 to the Listing Rules (the “Corporate Governance Code”). The audit committee consists of two independent non-executive Directors being Dr. Wong Wing Kuen Albert and Mr. Ding Jiangang and one non-executive Director being Mr. Hu Shihao. The chairman of the audit committee is Dr. Wong Wing Kuen Albert, who holds the appropriate professional qualifications as required under Rules 3.10(2) and 3.21 of the Listing Rules. The primary duties of the audit committee are to assist our Board by providing an independent view of the effectiveness of the financial reporting process, internal control and risk management systems of the Group, overseeing the audit process and performing other duties and responsibilities as assigned by our Board.


Remuneration Committee

We have established a remuneration committee (with effect from the Listing Date) with written terms of reference in compliance with Rule 3.25 of the Listing Rules and paragraph B.1 of the Corporate Governance Code. The remuneration committee consists of two independent non-executive Directors being Mr. Ding Jiangang and Mr. Chen Hengliu, and one executive Director being Mr. Fei Zhongmin. The remuneration committee is chaired by Mr. Ding Jiangang. The primary duties of the remuneration committee include, but are not limited to, the following: (i) making recommendations to our Board on our policy and structure for all remuneration of Directors and senior management and on the establishment of a formal and transparent procedure for developing policy on such remuneration; (ii) determining the specific remuneration packages of all Directors and senior management; and (iii) reviewing and approving performance-based remuneration by reference to corporate goals and objectives resolved by our Board from time to time.


Nomination Committee

We have established a nomination committee (with effect from the Listing Date) with written terms of reference in compliance with paragraph A.5 of the Corporate Governance Code. The nomination committee consists of two independent non-executive Directors being Mr. Ding Jiangang and Mr. Chen Hengliu, and one executive Director being Mr. Hu Yiping, who is the chairman of our Board and also acts as the chairman of the nomination committee. The primary functions of the nomination committee include, without limitation, reviewing the structure, size and composition of our Board, assessing the independence of independent non-executive Directors and making recommendations to our Board on matters relating to the appointment of Directors.

Stock Price

Dexin China Holdings Limited
(Stock No. 2019.HK)

HK$00.00

 

Last update:
Disclaimer